SEC-sourced researchBeta
AIDX
20/20 Biolabs, Inc.
Company comparison ↗
Data passport
- CIK
- 0001139685
- Exchange
- Nasdaq
- Business activity
- Services-Testing Laboratories · SIC 8734
- Financial inputs
- 6/6
- Filing date
- Oct 6, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 1,752,343.0000 | Mar 31, 2026 |
| December 2025 | 2,045,133.0000 | Mar 31, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 2,045,133.0000 | -3,738,821.0000 | -1,919,720.0000 | 4,137,357.0000 | 4,156,582.0000 | Mar 31, 2026 |
| December 2024 | 1,752,343.0000 | -5,551,667.0000 | -2,598,785.0000 | 3,584,408.0000 | 2,078,926.0000 | Mar 31, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
33/100
Profitability0
Growth67
Balance sheet0
Cash generation0
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $2.05M | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Previous period revenueRevenues | $1.75M | Jan 1, 2024 – Dec 31, 2024 | Mar 31, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$3.74M | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$1.92M | Jan 1, 2025 – Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Total assetsAssets | $4.14M | Dec 31, 2025 | Mar 31, 2026 | 10-K |
| Total liabilitiesLiabilities | $4.16M | Dec 31, 2025 | Mar 31, 2026 | 10-K |
New filings
- PRE 14AAIDX · 20/20 Biolabs, Inc.Oct 6, 2026 · Other
- 8-KAIDX · 20/20 Biolabs, Inc.Sep 18, 2026 · Current event
- 8-KAIDX · 20/20 Biolabs, Inc.Sep 10, 2026 · Current event
- 8-KAIDX · 20/20 Biolabs, Inc.Sep 2, 2026 · Current event
- DEFA14AAIDX · 20/20 Biolabs, Inc.Aug 19, 2026 · Other
- 8-KAIDX · 20/20 Biolabs, Inc.Aug 19, 2026 · Current event
- 424B3AIDX · 20/20 Biolabs, Inc.Aug 17, 2026 · Other
- 424B3AIDX · 20/20 Biolabs, Inc.Aug 17, 2026 · Other
- 8-KAIDX · 20/20 Biolabs, Inc.Aug 17, 2026 · Current event
- 10-QAIDX · 20/20 Biolabs, Inc.Aug 14, 2026 · Periodic
- 8-KAIDX · 20/20 Biolabs, Inc.Aug 5, 2026 · Current event
- 8-KAIDX · 20/20 Biolabs, Inc.Jul 22, 2026 · Current event
- 8-KAIDX · 20/20 Biolabs, Inc.Jul 1, 2026 · Current event
- DEFA14AAIDX · 20/20 Biolabs, Inc.Jun 23, 2026 · Other
- DEF 14AAIDX · 20/20 Biolabs, Inc.Jun 23, 2026 · Other
- PRE 14AAIDX · 20/20 Biolabs, Inc.Jun 1, 2026 · Other
- 8-KAIDX · 20/20 Biolabs, Inc.May 26, 2026 · Current event
- 424B3AIDX · 20/20 Biolabs, Inc.May 21, 2026 · Other
- 424B3AIDX · 20/20 Biolabs, Inc.May 21, 2026 · Other
- 10-QAIDX · 20/20 Biolabs, Inc.May 20, 2026 · Periodic